Market Cap

As of August 23, 2010: $3,896,218,000.00

Stock Chart

Cochlear - 30 Day Poll

Recent BLOGS About Cochlear Add New

There are no blogs to display.

Latest Company News

Cochlear FY Net Profit Up 19%, Nucleus 5 Sales Gain Momentum
Wall Street Journal - Aug 10, 2010
By Cynthia Koons and Neil Sands SYDNEY (Dow Jones)--The world's largest maker of inner ear implants, Cochlear Ltd. (COH.AU), said Tuesday that its full year net profit rose 19% as the roll out of ...
Cochlear posts 19% annual net profit increase - Finance News Network
Cochlear's annual profit up 19% - International Business Times AU
Cochlear Limited Announces Final Partially Franked Dividend
Reuters Key Development - Aug 9, 2010
WEEKEND ECONOMIST: Weakening worries
Business Spectator - Aug 6, 2010
The past month has seen sharemarkets and other growth assets climb a wall of worry, and that has remained the story over the last week. While economic indicators suggest global growth has slowed ...
Aquarius, Axa, BHP, Cochlear, NAB, Santos, Toll, Woodside: Stock Preview
Bloomberg - Jul 8, 2010
By Lisa Pham and Shani Raja - Jul 8, 2010 The following is a list of companies whose shares may rise or fall in Australia. This preview includes news announced after markets closed yesterday. All ...
Manhattan Scientifics Announces the Initiation of a Joint Project to Create Biological Metals for Medical Implants
Business Wire - Jul 8, 2010
LOS ALAMOS, NM--(BUSINESS WIRE)--The Australian government announced that Manhattan Scientifics (OTCBB:MHTX) and its existing industrial partner, Carpenter Technology Corporation (NYSE:CRS) have ...
Collaborative Research to Develop Metals for Medical Applications - AZoNano.com
Development of New Metals for Prosthetics Industries - Azom.com
Colorado Ear Implant Maker Fined $880,000 In Kickback Suit
FOXBusiness - Jun 9, 2010
By Tess Stynes Cochlear Ltd.'s (COH.AU) American unit agreed to pay $880,000 to settle allegations that paid various forms of illegal remunerations to physicians that prescribed the company's ...
Cochlear Americas agrees to settle kickback allegations - Denver Business Journal
Cochlear settles US legal dispute
Business Spectator - Jun 4, 2010
By a staff reporter Hearing device maker Cocohlear Ltd has settled a legal dispute in the US for $US950,000 ($A1.13 million) over allegations relating to sales programmes and other conduct alleged ...

Website

Videos related to Cochlear

Company Profile

Cochlear Limited (Cochlear) operates in the implantable hearing device industry. Its products include the cochlear implant system, Baha system, freedom accessories, speech processor upgrades and nucleus freedom implant.

Nucleus Freedom is the next generation of Cochlear's technology, including SmartSound 2, which brings clarity to everyday hearing.

Its bone conduction implant, the Baha system, helps people with conductive hearing loss, mixed hearing loss, as well as Single Sided Deafness (SSD). The Company has also introduced Nucleus Freedom speech processor technology to all of its Nucleus implant recipients. Cochlear's Nucleus Freedom implant with Contour Advance electrode and Nucleus Freedom implant with Straight electrode features an electronics platform with a microchip. During the fiscal year ended June 30, 2009, Cochlear acquired Percutis AB, a Swedish company.

Revenue & Earnings:
For the year ending 30th June 2009
 - Revenue up 15% to $694.7 million
 - Earnings before Interest and Tax (EBIT) up 10% to $183.3 million
 - Net Profit after Tax (NPAT) up 13% to $130.5 million

Upcoming Events:
Development of new products Cochlear Nucleus 5 and Cochlear Baha BP100 completed and available for market release


Terms & Rules

As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use

Before using this Biomedical Investing website

OR